These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2129719)

  • 21. Effect of ranitidine on gastroduodenal mucosal damage in patients on long-term non-steroidal anti-inflammatory drugs.
    Swift GL; Heneghan M; Williams GT; Williams BD; O'Sullivan MM; Rhodes J
    Digestion; 1989; 44(2):86-94. PubMed ID: 2693162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Gastric mucosa barrier and the effect of non-steroidal anti-inflammatory agents and corticosteroid hormones on the gastric and duodenal mucosa].
    Daskalov A; Chernev K
    Vutr Boles; 1988; 27(3):13-7. PubMed ID: 3061174
    [No Abstract]   [Full Text] [Related]  

  • 23. [Endoscopic study of digestive lesions caused by the use of nonsteroidal anti-inflammatory agents in rheumatic patients].
    van Linthoudt D; Kocher F; Ott H
    Schweiz Med Wochenschr; 1987 Apr; 117(16):604-8. PubMed ID: 3495881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cytoprotection of the gastric and duodenal mucosa (review of foreign literature)].
    Radbil' OS
    Klin Med (Mosk); 1990 Apr; 68(4):31-8. PubMed ID: 1695262
    [No Abstract]   [Full Text] [Related]  

  • 25. [The epidemiology of the gastroduodenal damage induced by aspirin and other nonsteroidal anti-inflammatory drugs].
    Dobrilla G; Benvenuti S; de Guelmi A
    Recenti Prog Med; 1997 May; 88(5):202-11. PubMed ID: 9244954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of coxibs in the strategies for gastrointestinal protection in patients requiring chronic non-steroidal anti-inflammatory therapy.
    Blandizzi C; Tuccori M; Colucci R; Fornai M; Antonioli L; Ghisu N; Del Tacca M
    Pharmacol Res; 2009 Feb; 59(2):90-100. PubMed ID: 19073262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonsteroidal anti-inflammatory drugs and ulcers.
    Soll AH
    West J Med; 1992 Oct; 157(4):465-8. PubMed ID: 1462553
    [No Abstract]   [Full Text] [Related]  

  • 28. Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury.
    Iijima K; Shimosegawa T
    World J Gastroenterol; 2015 Jul; 21(25):7709-17. PubMed ID: 26167071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NSAID, ulcers, and prostaglandins.
    Kimmey MB
    J Rheumatol Suppl; 1992 Nov; 36():68-73. PubMed ID: 1474538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of gastric and duodenal damage and protection.
    Hudson N; Hawthorne AB; Cole AT; Jones PD; Hawkey CJ
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():31-6. PubMed ID: 1577394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experimental study of NSAID effect on prostaglandine contents].
    Drozdov VN; Tkachenko EV; Varvanina GG; Trubitsyna IE
    Eksp Klin Gastroenterol; 2007; (5):77-80. PubMed ID: 18389602
    [No Abstract]   [Full Text] [Related]  

  • 32. [Protection of the gastroduodenal mucosa during a course of treatment with gastro-irritating drugs].
    Romboli L; Sullo B; Seppia M
    Minerva Gastroenterol; 1972; 18(4):227-35. PubMed ID: 4614118
    [No Abstract]   [Full Text] [Related]  

  • 33. NSAID-induced ulcers and prophylaxis. A reappraisal.
    Farr CM
    J Clin Gastroenterol; 1993 Oct; 17(3):187-8. PubMed ID: 8228076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C; Pelosini I
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What is the impact of the use of nonsteroidal anti-inflammatory drugs?
    Thomson AB; Fitzgerald AA
    Can J Gastroenterol; 1999 Mar; 13(2):115-7. PubMed ID: 10203428
    [No Abstract]   [Full Text] [Related]  

  • 36. Non steroidal anti-inflammatory drugs. Minimising the harm, maximising the benefit.
    Hawkey CJ
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):48-9. PubMed ID: 9615265
    [No Abstract]   [Full Text] [Related]  

  • 37. Investigation of gastric and duodenal mucosal defects caused by low-dose aspirin in patients with ischemic heart disease.
    Nema H; Kato M; Katsurada T; Nozaki Y; Yotsukura A; Yoshida I; Sato K; Kawai Y; Takagi Y; Okusa T; Takiguchi S; Sakurai M; Asaka M
    J Clin Gastroenterol; 2009 Feb; 43(2):130-2. PubMed ID: 18779739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Corticosteroids, non-steroidal antirheumatic agents and the gastroduodenum].
    Börsch G
    Z Rheumatol; 1984; 43(1):1-8. PubMed ID: 6608837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mucosal lesions associated with antiphlogistics--treatment and prevention].
    Aabakken L; Osnes M
    Tidsskr Nor Laegeforen; 1992 May; 112(13):1705-7. PubMed ID: 1509428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comprehensive assessment of the gastroduodenal mucosa before and after methylprednisolone pulse-therapy in children with chronic glomerulonephritis].
    Zokirov NZ; Sergeeva TV; Shavrov AA; Klochkov SAq ; Ryzhkova LA; Panchenko EL; Chumakova OV
    Urol Nefrol (Mosk); 1998; (3):32-6. PubMed ID: 9644988
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.